ICMR to carry out nationwide serosurvey to find out extent of exposure of COVID-19


PTI, Jul 10, 2020, 12:52 PM IST

New Delhi: The ICMR on Thursday, July 9 said a nationwide serosurvey to determine the exposure of the novel coronavirus among the population will be carried out as a follow-up to a similar study conducted in May, the results of which are yet to be released.

The Indian Council of Medical Research (ICMR) will conduct a ‘serosurvey’ which involves testing blood serum of people to check for the prevalence of antibodies against coronavirus infection.

The final results of the serosurvey conducted by the ICMR in May, which focused on infections of mid-April is still under process, Rajesh Bhushan, Officer on Special Duty in the Union Health Ministry said on Thursday.

“The serosurvey that ICMR conducted across the country focused on infections of mid-April and preliminary findings were shared. As you know all such sero-surveillance studies or any other scientific study is subject to peer-review and those inputs are also incorporated. So that process is going on,” he told reporters.

“We will be in a position to share it once that gets over,” he said.

The ICMR had earlier said on the basis of the data compiled from 65 districts out of 83 districts across the country in the first part of the sero-surveillance study, 0.73 percent of the population surveyed showed evidence of past exposure to SARS-CoV-2.

Bhushan further said the findings of the serosurvey, which has been done in Delhi by the National Centre for Disease Control (NCDC) as a part of which 22,000 samples were collected from June 27 to July 5 from 11 districts, is being processed.

“In the near future, ICMR is planning a follow-up serosurvey pan-India to the earlier serosurvey that they had done for mid-April infections,” Bhushan explained.

“The serosurvey conducted in May had two parts estimating the fraction of the general population that has been infected with SARS-CoV-2 and estimating the number of people who have been infected with coronavirus in containment zones of hotspot cities,” ICMR officials had earlier said.

The IgG antibodies against an infection take around 15 days to develop in the body.

India saw a record single-day surge of 24,879 coronavirus infections, which pushed the nationwide COVID-19 tally to 7,67,296 on Thursday, while the death toll climbed to 21,129 with 487 new fatalities, the Health Ministry data updated at 8 am showed.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Did not get any letter on allegations against Prajwal Revanna: Vijayendra

Yoga officially makes debut in Pakistan

Kerala: ‘Kallakkadal’ red alert revised to orange warning

Lok Sabha Elections 2024: Yogi equates inheritance tax with Aurangzeb’s ‘jizya’ again at Guna rally, hails Scindias for ‘fighting Afghans’

PM Modi believes in politics of ‘santushtikaran’ not ‘tushtikaran’: Bihar Deputy CM Vijay Sinha

Political parties seek Muslim electorate, yet resist Muslim representation: AIMIM’s Jaleel

Congress leader Tharoor criticizes BJP’s tax proposals, alleging desperation for electoral success

Related Articles More

Five soldiers injured in terror attack ahead of Lok Sabha polls in J-K’s Poonch

BJP files complaint against Himachal speaker for violating MCC

Tanur custodial death case: CBI arrests four Kerala policemen

Air India reduces cabin baggage allowance to 15 kg for lowest fare segment

Three held for stalking, harassing woman in Nagpur

MUST WATCH

Skin Rash, Causes, Signs and Symptoms

11 bullets found in python’s body!

K. Jayaprakash Hegde Sharing His Memories

Grafting Jack Anil

Heat Illness


Latest Additions

Five soldiers injured in terror attack ahead of Lok Sabha polls in J-K’s Poonch

BJP files complaint against Himachal speaker for violating MCC

Vitla: KSRTC bus driver, 2 children injured after windshield shatters

Tanur custodial death case: CBI arrests four Kerala policemen

Haveri: Woman tied to electric pole, thrashed after son elopes with girl, six arrested

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.